245620 — Eone Diagnomics Genome Center Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Eone Diagnomics Genome Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,025	60,983	27,597	4,985	9,735
Net Total Accounts Receivable
Net Total Receivables	21,729	23,766	13,988	20,392	23,987
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46,021	95,408	59,230	41,612	46,252
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11,133	12,173	54,404	87,894	87,761
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	96,400	160,305	186,938	192,011	173,519
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	43,572	83,445	59,905	108,451	87,548
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	56,958	90,292	128,830	160,062	135,294
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	39,442	70,013	58,108	31,948	38,224
Total Liabilities & Shareholders' Equity	96,400	160,305	186,938	192,011	173,519
Total Common Shares Outstanding